That projection is far higher than the global market valued in 2010 at $16 billion. Markets for infection control devices and products were $8.3 billion in the year 2010 and are expected to reach $10.3 billion by 2011. This market is forecasted to cross $18.3 billion by 2016 at a CAGR of 12 percent.
Additionally, the global market for pharmaceutical treatments is expected to reach $6 billion by 2016 at a 5.8 percent CAGR. The U.S. holds nearly half of the global market for healthcare-association infection products.
Related Articles on Healthcare-Acquired Infections:
10 Proven Ways to Reduce Hospital Readmissions
Basic Infection Prevention Saved Children’s Hospitals $104M Over 5 Yrs
Readmissions in New York Cost $3.7B
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
